February 05, 2008 - -Geron Corporation (Nasdaq:GERN) announced that it has received U.S. Patent 7,326,572 with claims covering a widely used method for producing endoderm cells from human embryonic stem cells (hESCs). The production of endoderm cells is a critical step in generating pancreatic islet cells from hESCs, which Geron is developing for potential use in treating diabetes... Geron's Press Release-
Thursday, February 7, 2008
Geron, Second U.S. Patent for Production of Pancreatic Islets from Human Embryonic Stem Cells
February 05, 2008 - -Geron Corporation (Nasdaq:GERN) announced that it has received U.S. Patent 7,326,572 with claims covering a widely used method for producing endoderm cells from human embryonic stem cells (hESCs). The production of endoderm cells is a critical step in generating pancreatic islet cells from hESCs, which Geron is developing for potential use in treating diabetes... Geron's Press Release-
